Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05128006 · ClinicalTrials.gov registry record
Direct-to-patient Teledermatology and Computer-assisted Diagnosis
A clinical trial of New Patient Use of Teledermatology Mobile App, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- 63,200
- Enrollment target
- 3
- Study locations
NCT05128006: Recruiting study of New Patient Use of Teledermatology Mobile App, sponsored by VA Office of Research and Development.
NCT05128006 is a study of New Patient Use of Teledermatology Mobile App that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 63,200 participants. The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05128006, a study of New Patient Use of Teledermatology Mobile App, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- 63,200 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study will examine access to dermatology care. The operational partner will implement a direct-to-new patient teledermatology clinical care pathway while the research will study the effects of that implementation, use data associated with deployment to develop and test an Artificial Intelligence system, and understand key stakeholders' attitudes regarding and readiness for remote dermatology care.
Primary Outcome
Proportion of in-person dermatology visits that are for new dermatology patients at facility level
Conditions Studied
Interventions
- OTHER New patient teledermatology visit
Study Locations (3)
California
- San Francisco VA Medical Center, San Francisco, CA - San Francisco
Colorado
- Rocky Mountain Regional VA Medical Center, Aurora, CO - Aurora
Georgia
- Atlanta VA Medical and Rehab Center, Decatur, GA - Decatur
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63,200 participants |
| Start Date | 2022-11-07 |
| Est. Completion | 2026-09-30 |
What NCT05128006 shows while recruiting
NCT05128006 is an observational study that tracks outcomes without assigning an intervention. Its 63,200 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with New Patient Use of Teledermatology Mobile App appearing as the primary indexed condition, and to 1 intervention - of which New patient teledermatology visit is the first listed.
NCT05128006 reports a single indexed study location in California, Colorado, Georgia.
Frequently Asked Questions
What is clinical trial NCT05128006 about?
NCT05128006 is a clinical study titled "Direct-to-patient Teledermatology and Computer-assisted Diagnosis". This study will examine access to dermatology care. The operational partner will implement a direct-to-new patient teledermatology clinical care pathway while the research will study the effects of that implementation, use data associated with deployment to develop and test an Artificial Intelligenc...
What is the current status of trial NCT05128006?
This trial is currently recruiting. The enrollment target is 63,200 participants. The study started on 2022-11-07. Estimated completion is 2026-09-30.
What conditions does trial NCT05128006 study?
This clinical trial studies the following conditions: New Patient Use of Teledermatology Mobile App.
What interventions are being tested in trial NCT05128006?
The interventions under investigation include: New patient teledermatology visit (OTHER).
Who is sponsoring clinical trial NCT05128006?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05128006 being conducted?
This trial has 3 study locations across California, Colorado, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06003192 · 63,000 participants · NA
Screen Smart: Using Digital Health to Improve HIV Screening and Prevention
- NCT05723614 · 61,770 participants · NA
TRUsted rEsidents and Housing Assistance to Decrease Violence Exposure in New Haven
- NCT04473833 · 65,000 participants · NA
Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer
- NCT03752840 · 60,200 participants · NA
Village-Integrated Eye Worker Trial II
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI